I have to be honest right off the bat - I didn't think Philips (NYSE:PHG) had what it would take to really get the business turnaround they needed. Yet, here we are with this European conglomerate reporting steady mid-single digit organic growth and improving margins. While I definitely missed the potential for Philips' self-improvement in 2012 (and the stock performance that has doubled the S&P 500), I still have some long-term fundamental questions about where Philips stands against the competition and whether sell-side analysts (and investors) are expecting too much from this company.

Guide To Oil And Gas Plays: We've got your comprehensive guide to oil and gas shales in North America.

Progress Continues ... but From a Low Base
With third quarter earnings back in October, Philips delivered another solid mid-single digit organic growth performance. Revenue rose about 5%, with healthcare up 7%, lighting up 4% and consumer products up 3%. These are solid numbers in a difficult operating environment, though the cynic in me points to the fact that the comps were easier given Philips' dismal prior performance. Profits also continue to improve. Reported gross margin eased off about 30 basis points, but the company's "clean" EBITA was up 22% from last year, with a major improvement in consumer (up almost 100%) and more sluggish performance in healthcare (up 26%) offsetting a double-digit decline in lighting (down about 57%). Healthcare and consumer continue to drive the profit story, though, as both EBITAs make up nearly 22% of the company's sales.

Healthcare - Orders Are up, but What About Tomorrow?
With Philips' U.S. healthcare business up a bit, the company is doing alright relative to other vendors of big ticket items like imaging systems. Europe was surprisingly strong, though, with orders showing double-digit growth (the first positive performance in almost three years) on flat sales, and China continues to be a source of growth.

I have my concerns about Philips' long-term competitiveness, though. Philips is well behind Hologic (Nasdaq:HOLX) and General Electric (NYSE:GE) in tomo for mammography and there wasn't much from the company at the recent Radiological Society of North America meeting. What's more, with both Mindray (NYSE:MR) and Samsung (OTC:SSNLF) looking to up their game in imaging for emerging markets, I'm not sure about the sustainability of Philips' healthcare improvements.

SEE: How To Decode A Company's Earnings Report

Lighting Still Looks Like a Tough Business
Lighting has been a rough business for all of the major players, so much so that Siemens (NYSE:SI) is still eager to dispose of its Osram lighting business (with a spin-off now expected in the first half of 2013). There have certainly been some signs of progress for Philips, with LED-based sales up 51% in the third quarter (about one-quarter of sales). Sustainability remains a key question, though, and even these improved results are not all that impressive as a percentage of revenue or relative to the capital invested.

A Good Job so Far, but How Much Is in the Tank?
Philips CEO Frans van Houten deserves quite a lot of credit for leading Philips' turnaround to this point, and three straight good quarters (despite a worsening operating environment pretty much around the globe) is a noteworthy accomplishment.

As I've said, though, I have my concerns about the durability/sustainability of this turnaround. I think Philips may actually emerge as a leader in lighting, if for no other reason than GE and Siemens have seemed to deprioritize these businesses after years of disappointment. On the healthcare side, though, I question whether the company can keep up with rivals like GE, Siemens and Hologic, and whether reimbursement will continue to support growth in imaging and respiratory care. Likewise, I question whether Philips can win the long-term battle in consumer appliances against its Korean and Chinese rivals.

The Bottom Line
My biggest concern with Philips as a stock, though, is the level of expectations already in the stock price. Today's price already seems to assume that Philips is going to lift its free cash flow margin into the mid-to-high single digits.

While that's not really ambitious at all relative to comparables like GE or Siemens, it's something this company hasn't done in over a decade. So while it's true that there's plenty of potential in Philips if the company can become a consistent double-digit ROIC generator and deliver free cash flow conversion margins in the low teens, that would seem to be a pretty ambitious call. Nevertheless, Philips is not all that expensive today on a trailing EV/EBTIDA basis, and that solid 3% dividend yield gives investors a reason to hang on and see if Philips really is capable of delivering top-tier performance.

At the time of writing, Stephen D. Simpson did not own any shares in any company mentioned in this article.

Related Articles
  1. Investing News

    What You Can Learn from Carl Icahn's Mistakes

    Carl Icahn has been a stellar performer in the investment world for decades, but following his lead these days could be dangerous.
  2. Stock Analysis

    Analyzing Altria's Return on Equity (ROE) (MO)

    Learn about Altria Group's return on equity (ROE) and analyze net profit margin, asset turnover and financial leverage to determine what is causing its high ROE.
  3. Investing

    What Investors Need to Know About Returns in 2016

    Last year wasn’t a great one for investors seeking solid returns, so here are three things we believe all investors need to know about returns in 2016.
  4. Investing News

    Icahn's Bet on Cheniere Energy: Should You Follow?

    Investing legend Carl Icahn continues to lose money on Cheniere Energy, but he's increasing his stake. Should you follow his lead?
  5. Stock Analysis

    Analyzing Google's Return on Equity (ROE) (GOOGL)

    Learn about Alphabet's return on equity. How has its ROE changed over time, how does it compare to its peers and what factors are driving ROE for the company?
  6. Investing News

    Is Buffett's Bet on Oil Right for You? (XOM, PSX)

    Oil stocks are getting trounced, but Warren Buffett still likes one of them. Should you follow the leader?
  7. Stock Analysis

    The Top 5 Micro Cap Biotechnology Stocks for 2016 (BSTC, OSIR)

    Discover some of the most promising micro-cap biotechnology stocks that investors can consider for their 2016 investment portfolio.
  8. Investing News

    Chipotle Served with Criminal Probe

    Chipotle's beat muted expectations and got a clear bill from the CDC, but it now appears that an investigation into its E.coli breakout has expanded.
  9. Stock Analysis

    Analyzing Sprint Corp's Return on Equity (ROE) (S)

    Learn about Sprint's return on equity. Find out why its ROE is negative and how asset turnover and financial leverage impact ROE relative to Sprint's peers.
  10. Stock Analysis

    Why Alphabet is the Best of the 'FANGs' for 2016

    Alphabet just impressed the street, but is it the best FANG stock?
RELATED FAQS
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  5. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  6. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>
COMPANIES IN THIS ARTICLE
Trading Center